{
    "RADCURE-3696": {
        "question": "Age: 60.3, Sex: Male, ECOG PS: ECOG 1, Smoking PY: 0, Smoking Status: Non-smoker, Ds Site: Oropharynx, Subsite: Base of Tongue, T: T3, N: N0, M : M0, Stage: III, Path: Adenocarcinoma, HPV: Negative, Tx Modality: RT alone, Chemo? : none, Dose: 70.0, Fx: 35, Local: none, Regional: none, Distant: none, 2nd Ca: none, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck adenocarcinoma, especially in HPV-negative oropharyngeal cancers. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "**Step 1: Initial Assessment (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the cervical vertebrae, the airway (pharynx and larynx), and soft tissues of the oropharynx.\n- The green masked region of interest (ROI) is located anterior to the cervical spine, likely corresponding to the base of tongue or oropharyngeal soft tissue.\n- The ROI appears well-defined and localized, without obvious invasion into adjacent bony structures.\n- No gross abnormalities such as large masses or extensive soft tissue swelling are noted outside the ROI.\n- The airway is patent, and no significant lymphadenopathy or distant metastases are visible in this slice.\n\n**Step 2: Mapping Bounding Boxes**\n\n- Bounding box 1: [263, 130, 93, 263, 211, 124]\n  - This box is narrow in the z-axis (263 to 263), indicating a single slice or thin volume.\n  - The y-axis spans from 130 to 211, and x-axis from 93 to 124.\n  - This likely corresponds to the green ROI region in the oropharynx/base of tongue area.\n\n- Bounding box 2: [256, 234, 124, 256, 266, 157]\n  - Also narrow in z-axis (256 to 256).\n  - Y-axis from 234 to 266, x-axis from 124 to 157.\n  - This may correspond to a region posterior or inferior to the first box, possibly representing a lymph node or adjacent soft tissue structure.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 60.3-year-old male with oropharyngeal adenocarcinoma located at the base of tongue.\n- Tumor staging is T3, indicating a large primary tumor but no nodal involvement (N0) or distant metastasis (M0).\n- HPV status is negative, which is associated with a less favorable prognosis compared to HPV-positive tumors.\n- ECOG performance status is 1, indicating slight symptoms but generally ambulatory.\n- Treatment is radiation therapy alone, 70 Gy in 35 fractions, without chemotherapy.\n- The ROI corresponds to the primary tumor site; bounding boxes likely delineate tumor and possibly adjacent lymphatic regions.\n- No evidence of regional or distant spread on imaging.\n- Given the T3N0M0 staging and HPV-negative status, the prognosis is intermediate; radiation alone may be sufficient but carries some risk of local recurrence.\n- The absence of chemotherapy may reduce systemic control but is consistent with N0 disease.\n- Overall, the patient has a reasonable chance of survival with definitive radiation therapy.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows a localized oropharyngeal adenocarcinoma at the base of tongue (green ROI).\n- Bounding boxes correspond to the tumor volume and possibly adjacent lymphatic regions.\n- Clinical staging (T3N0M0), HPV-negative status, and treatment with radiation alone suggest intermediate prognosis.\n- The patientâ€™s performance status and lack of nodal disease favor a positive outcome.\n- From a radiation oncology perspective, the dose and fractionation are appropriate for curative intent.\n- Survival probability is favorable but not excellent due to HPV negativity and tumor size.\n\n('Answer:Alive',)",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate-radiation oncologist": "No",
        "Round 2-Turn 1-ask_gap-radiation oncologist": "Yes. A medical oncologist is needed to provide expertise on systemic therapy options and chemotherapy considerations, especially given the HPV-negative status and T3 staging, to optimize overall treatment planning beyond radiation therapy alone.",
        "Round 2-Turn 1-gap_identified-assistant": "A unique, useful, and specific expert recommendation extracted from the discussion is:\n\n- Consult a medical oncologist to provide expertise on systemic therapy options and chemotherapy considerations, especially given the HPV-negative status and T3 staging, to optimize overall treatment planning beyond radiation therapy alone.",
        "Round 2-Turn 1-gap_recruit-recruiter": "1. Medical Oncologist - Your expertise is strictly limited to systemic therapy decisions, including chemotherapy and immunotherapy in head and neck cancers, with a focus on HPV-negative oropharyngeal adenocarcinoma. - Hierarchy: Medical Oncologist == Radiation Oncologist",
        "Round 2-Turn 1-gap_recruited_assessment-medical oncologist": "**Step 1: Initial Assessment (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the cervical vertebrae, the airway (pharynx and larynx), and soft tissues of the oropharynx.\n- The green masked region of interest (ROI) is located anterior to the cervical spine, in the oropharyngeal region, likely corresponding to the base of tongue or adjacent soft tissue.\n- The ROI appears well-defined and localized without obvious invasion into the cervical vertebrae or surrounding bony structures.\n- No gross abnormalities such as large masses or extensive soft tissue swelling are noted outside the ROI.\n- The airway is patent without obstruction.\n- No significant lymphadenopathy or distant metastases are visible in this slice.\n\n**Step 2: Mapping Bounding Boxes**\n\n- Bounding box 1: [263, 130, 93, 263, 211, 124]\n  - This box is narrow in the z-axis (263 to 263), indicating a single slice or thin volume.\n  - The y-axis spans from 130 to 211, and x-axis from 93 to 124.\n  - This likely corresponds to the green ROI region in the oropharynx/base of tongue area, consistent with the primary tumor site.\n\n- Bounding box 2: [256, 234, 124, 256, 266, 157]\n  - Also narrow in z-axis (256 to 256).\n  - Y-axis from 234 to 266, x-axis from 124 to 157.\n  - This region is posterior and inferior to the first bounding box, possibly representing a regional lymph node or adjacent soft tissue structure.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 60.3-year-old male with oropharyngeal adenocarcinoma located at the base of tongue.\n- Tumor staging is T3 (large primary tumor), N0 (no regional lymph node involvement), M0 (no distant metastasis).\n- HPV-negative status, which is associated with a less favorable prognosis compared to HPV-positive tumors.\n- ECOG performance status 1 indicates the patient is ambulatory with some symptoms but generally functional.\n- Treatment consists of radiation therapy alone (70 Gy in 35 fractions), without chemotherapy.\n- The ROI and bounding box 1 correspond to the primary tumor volume.\n- Bounding box 2 may represent a regional lymphatic area, but no nodal involvement is clinically or radiographically evident.\n- Absence of nodal or distant disease suggests localized disease.\n- HPV-negative status and T3 staging confer an intermediate prognosis.\n- Radiation alone is an acceptable treatment for T3N0M0 disease, but the lack of chemotherapy may slightly reduce systemic control.\n- Overall, the patient has a reasonable chance of survival with definitive radiation therapy given the localized disease and good performance status.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows a localized oropharyngeal adenocarcinoma at the base of tongue (green ROI).\n- Bounding boxes correspond to the tumor volume and possibly adjacent lymphatic regions without evident nodal disease.\n- Clinical staging (T3N0M0), HPV-negative status, and treatment with radiation alone suggest an intermediate prognosis.\n- The patient's good performance status and absence of nodal or distant spread favor a positive outcome.\n- Radiation dose and fractionation are appropriate for curative intent.\n- Survival probability is favorable but not excellent due to HPV negativity and tumor size.\n\n('Answer:Alive',)",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-medical oncologist": "No",
        "Round 2-role-comment": "radiation oncologist:alive|medical oncologist:alive",
        "Round 2-num_agents": 2,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Alive',)"
    }
}